Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

European Research Council grant · Running

TF-KINETIX Why do transcription factors bind what they bind when they bind?

Coordinator
Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis, Netherlands
Runs
1 November 2024 to 31 October 2029
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101162742

What the project is doing

In the project's own words, from its summary on CORDIS.

Transcription factor binding is orchestrated by a complex interplay between DNA sequence, chromatin composition, protein interactions, and transcription factor concentration. These regulatory features determine the binding kinetics: how long it takes for a certain amount of transcription factor to associate, and subsequently dissociate from specific binding sites. These kinetics are in turn determined by the thermodynamic properties of each interaction.

It is currently not possible to measure the biochemical kinetics of transcription factor binding across the chromatinized genome inside the nucleus of a cell. To understand why a transcription factor binds to a specific chromatin:DNA-sequence context in a specific cellular state at a specific time, we need to measure how chromatin and DNA influence the biochemical parameters that underpin transcription factor binding.

This gap in knowledge limits our functional understanding of why a binding event occurs, and it hampers accurate predictions of transcription factor binding. Here, I will establish a novel proteomics and genomics toolkit to decipher the regulation of transcription factor binding kinetics to the chromatinized genome. I will resolve interactome- and genome-wide binding kinetics of three lung-cancer-associated transcription factors.

By delineating association and dissociation rates, and changes in disorder and binding energy, of all binding events across the genome, I aim to obtain a quantitative understanding of how the proteome composition, epigenetic landscape, and genetic code dictate transcription factor binding. Finally, I will build predictive binding models to engineer cell-state-specific transcription factor binding profiles. Together, this will transform our knowledge about transcription factor binding into a functional understanding where instead of observing, we understand why each binding event occurs when it occurs, and how we can steer these events.

Topics

Who is involved

OrganisationCityCountryRole
Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek ZiekenhuisAmsterdamNetherlandsCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI